Pharmacy
M2-PK is a modern enzyme biomarker and has been identified as the key enzyme in polyps and intestinal tumours. The enzyme M2-PK is completely independent of the presence of blood in the stool.
An entirely different process is immunological blood in stool detection (iFOB) for the determination of human hemoglobin (Hb). This procedure depends on the presence of a source of bleeding in the intestine (indirect method). The modern immunological blood in stool detection (iFOB) has significant advantages over the outdated biochemical blood-in-stool test (FOB); so-called “guaiac” or “hemoccult” test. The modern immunological blood in stool detection (iFOB) of hemoglobin (Hb) represents a significant improvement over the previously used guaiac test (FOB). Only specific antibodies against human hemoglobin (Hb) used.
The strength of testing ScheBo® • M2-PK + Hb™ combination chair test is primarily due to the fact that M2-PK enzyme biomarker- and immunological “blood-in-stool” detection (Hb) Measure completely independent and different things and therefore each makes an additional important contribution to colorectal cancer prevention. Based on combined testing of M2-PK and Hb Is it possible to detect both bleeding and non-bleeding intestinal polyps or tumors.
Sample material: tiny stool sample
The test with the central pharmaceutical number (PZN) 0242826 is only available in pharmacies in Germany. The laboratory costs are also paid with the purchase price; further costs are only the postage for a large letter to send the stool sample to our laboratory.